Use of Clinically Informed Strategies and Diagnostic Yields of Genetic Testing for Fetal Structural Anomalies Following a Non‐Diagnostic Microarray Result: A Population‐Based Cohort Study

Citations Over TimeTop 10% of 2025 papers

Abstract

Multidisciplinary review and comprehensive clinical information can inform the selection of strategies for expanded genetic testing after non-diagnostic microarray for fetal anomalies within a publicly funded health care system.

Related Papers

• → The GENCODE exome: sequencing the complete human exome(2011)63 cited
• → Clinical Exome Performance for Reporting Secondary Genetic Findings(2014)35 cited
• → Diagnostic Exome Sequencing — Are We There Yet?(2012)26 cited
• → The current landscape of clinical exome and genome reanalysis in the U.S.(2024)3 cited
• → Exome Sequencing in Mendelian Disorders(2010)1 cited